Earth Science Tech (ETST) Net Cash Flow Growth (3y) (2014 - 2026)
Earth Science Tech (ETST) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -49.94% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -62.71% |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 294.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294.78% |
| Dec 31, 2025 | -235.20% |
| Sep 30, 2025 | 63.36% |
| Jun 30, 2025 | -88.80% |
| Mar 31, 2025 | 405.64% |
| Dec 31, 2024 | -371.57% |
| Sep 30, 2024 | 112.75% |
| Jun 30, 2024 | 380.79% |
| Mar 31, 2024 | 338.96% |
| Dec 31, 2023 | 41.93% |
| Sep 30, 2023 | 274.59% |
| Jun 30, 2023 | 241.76% |
| Mar 31, 2023 | -34.62% |
| Dec 31, 2022 | -53.88% |
| Sep 30, 2022 | 16.51% |
| Jun 30, 2022 | 49.75% |
| Mar 31, 2022 | -35.53% |
| Dec 31, 2021 | 52.67% |
| Sep 30, 2021 | 4.59% |
| Jun 30, 2021 | -27.23% |